Image

Summary

The regulation of similar biotherapeutic products varies widely among the different Latin American countries. While some of them are yet to introduce their own regulation, others — like Colombia, Brazil and Mexico — have opened ways to cheaper, complex and safe biological treatment for patients. However, many things need improving and a lot of experience is still necessary to develop a mature LATAM Biosimilars Market.

Biosimilars Latam - Colombia 2020 Forum is a unique and effective meeting point to share the information and experience Latin America’s Pharmaceutical Industry needs to develop a dynamic and thriving biosimilars market.

Join us in Colombia and trigger a quantum leap in Latin American Healthcare!

Who will
you meet?

More than:

 

0
Participants
0
Companies



HCPs

Patients

Academy

Institutions

Associations

Service Providers

Governmental Agencies

Industry Executives from Latam



From these areas:
  • Biosimilars
  • Biobetters
  • Biotechnology
  • Biotherapeutics
  • Analytical science
  • Regulatory compliance
  • Quality Control
  • Clinical immunology
  • Scientific Affairs
  • Pharmacovigilance
  • Research
  • Investment
  • Regulatory
  • Business Development
  • Marketing

Programme at a Glance

1. Regulation Update - Colombia, Brazil, Argentina and Mexico
Coming soon
2. Latam Biosimilars's Insight
3. Perception on Biosimilars from Local Patiens and HCPs.
4. Where the Colombian Industry should go?
5. How to Start Developing Biosimilars in Colombia.
6. Regulatory Harmonization Activities
Full programme in the PDF Agenda

Keep me updated



About "JackLeckerman"

JackLeckerman Company has been established as a business intelligence event services and the promotion of global summits, strategic conferences, open forums and professional training.

©2020 JackLeckerman. All Rights Reserved. Designed By

Search